Related Experiment Videos
Massive periretinal proliferation: a logical approach to therapy
Abstract:
Massive periretinal proliferation (MPP), a serious complication of retinal surgery is caused by proliferation and fibrous metaplasia of cells mostly deriving from retinal pigment epithelium and retinal glial cells. Contracting fibrous membranes in the vitreous and on and also under the retina cause the intraocular changes of MPP. Early signs such as increased "tobacco dust," pigmented clumps in the vitreous, subtle preretinal and even retroretinal membranes are usually overlooked. The late signs such as starfolds, irregular retinal folds and funnel-shaped detachments are well known. The pathogenesis of the clinically visible signs is described and a four stage classification of the disease is given. Based on the improved understanding of this disease, a new therapeutic approach is presented, with the technique of pars plana vitreous surgery. Not only vitreous membranes but also preretinal membranes are removed. Forty-seven consecutive patients who suffered from severe massive periretinal proliferation were operated on with this technique and followed for six months or more. Seventeen patients (36%) had an attached retina. Twelve patients had a major visual improvement. The major postoperative complication is phthisis bulbi (10 eyes, 21%).
Insights
Massive periretinal proliferation (MPP) after retinal surgery can lead to vision loss. A new surgical technique shows promise in reattaching the retina and improving vision in patients with severe MPP.
Area of Science:
- Ophthalmology
- Retinal Surgery
- Vitreoretinal Diseases
Background:
- Massive periretinal proliferation (MPP) is a severe complication following retinal surgery.
- It involves the proliferation and metaplasia of retinal pigment epithelium and glial cells, forming contractile membranes.
- Early signs are often missed, while late signs include starfolds and retinal detachments.
Observation:
- The pathogenesis and clinical signs of MPP were described.
- A four-stage classification system for MPP was proposed.
- A novel therapeutic approach using pars plana vitreous surgery was developed.
Findings:
- The new surgical technique involves removing both vitreous and preretinal membranes.
- In 47 patients with severe MPP, 36% achieved retinal reattachment after surgery.
- 12 patients experienced significant visual improvement, though 21% faced phthisis bulbi.
Implications:
- Pars plana vitreous surgery offers a new therapeutic option for severe MPP.
- This approach can improve retinal reattachment rates and visual outcomes.
- Careful patient selection and surgical technique are crucial to minimize complications like phthisis bulbi.